Comprehensive Profiling of Surface Gangliosides Extracted from Various Cell Lines by LC-MS/MS.
LC-MS/MS
cancer cell
cell surface
ganglioside
glycosylation
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
26 10 2019
26 10 2019
Historique:
received:
30
09
2019
revised:
20
10
2019
accepted:
23
10
2019
entrez:
14
11
2019
pubmed:
14
11
2019
medline:
9
7
2020
Statut:
epublish
Résumé
Gangliosides act as a surface marker at the outer cellular membrane and play key roles in cancer cell invasion and metastasis. Despite the biological importance of gangliosides, they have been still poorly characterized due to the lack of effective analytical tools. Herein, we performed molecular profiling and structural elucidation of intact gangliosides in various cell lines including CFPAC1, A549, NCI-H358, MCF7, and Caski. We identified and quantified a total of 76 gangliosides on cell membrane using C18 LC-MS/MS. Gangliosides found in each cell line exhibited high complexity and diversity both qualitatively and quantitatively. The most abundant species was GM3(d34:1) in CFPAC1, NCI-H358, and MCF7, while GM2(d34:1) and GM1(d34:1) were major components in A549 and Caski, respectively. Notably, glycan moieties showed more diversity between cancer cell lines than ceramide moieties. In addition, noncancerous pancreatic cell line (hTERT/HPNE) could be distinguished by gangliosides containing different levels of sialic acid compared with cancerous pancreatic cell line (CFPAC1). These results clearly demonstrated the feasibility of our analytical platform to comprehensive profile of cell surface gangliosides for identifying cell types and subgrouping cancer cell types.
Identifiants
pubmed: 31717732
pii: cells8111323
doi: 10.3390/cells8111323
pmc: PMC6912501
pii:
doi:
Substances chimiques
Ceramides
0
Gangliosides
0
Polysaccharides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Sci Rep. 2018 Jul 20;8(1):10993
pubmed: 30030471
FEBS Lett. 2010 May 3;584(9):1872-8
pubmed: 19913543
Biochimie. 2003 Mar-Apr;85(3-4):455-63
pubmed: 12770784
Cell Death Differ. 2012 Jan;19(1):170-9
pubmed: 21681193
Cancer Res. 2005 Jun 15;65(12):5428-38
pubmed: 15958592
J Immunol Methods. 1986 May 1;89(1):111-6
pubmed: 3517170
Anal Chem. 2018 Jan 2;90(1):208-224
pubmed: 29049885
Lung Cancer. 1997 Aug;18(1):21-33
pubmed: 9268945
Lipids. 2000 Sep;35(9):937-45
pubmed: 11026613
OMICS. 2015 Feb;19(2):115-30
pubmed: 25611337
Front Oncol. 2019 May 14;9:380
pubmed: 31157165
Nat Rev Drug Discov. 2005 Jun;4(6):477-88
pubmed: 15931257
Front Oncol. 2014 May 23;4:114
pubmed: 24904828
J Immunol. 2003 Apr 1;170(7):3488-94
pubmed: 12646609
Anal Chem. 2017 Nov 21;89(22):12425-12432
pubmed: 29058414
Biochim Biophys Acta. 1999 Jan 29;1437(1):93-9
pubmed: 9931455
Nature. 2016 May 25;534(7605):55-62
pubmed: 27251275
Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12646-51
pubmed: 20616019
Front Immunol. 2014 Jul 21;5:325
pubmed: 25101077
J Biol Chem. 1957 May;226(1):497-509
pubmed: 13428781
Bioanalysis. 2009 Oct;1(7):1307-27
pubmed: 21083053
J Cancer Res Clin Oncol. 2009 Aug;135(8):1005-13
pubmed: 19125296
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11041-6
pubmed: 16040804
Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5376-5382
pubmed: 30819900
Expert Rev Anticancer Ther. 2017 Oct;17(10):889-904
pubmed: 28780888
Clin Transl Oncol. 2010 Dec;12(12):788-93
pubmed: 21156409
Breast Cancer Res. 2010;12(3):204
pubmed: 20550729
J Proteome Res. 2014 Feb 7;13(2):961-8
pubmed: 24303873
Cancer Res. 2001 May 15;61(10):4244-52
pubmed: 11358851
Anal Chem. 2017 Jul 18;89(14):7808-7816
pubmed: 28643517
Proc Natl Acad Sci U S A. 2004 Nov 16;101(46):16204-9
pubmed: 15534203
J Biol Chem. 2006 Jun 30;281(26):18145-55
pubmed: 16636068
Nature. 1975 Nov 6;258(5530):43-9
pubmed: 1102991
Methods Mol Biol. 1998;76:183-95
pubmed: 9664354
J Lipid Res. 2009 Apr;50 Suppl:S97-102
pubmed: 19029065
Oncotarget. 2016 Jul 5;7(27):41172-41185
pubmed: 27172791
Glycoconj J. 2012 Dec;29(8-9):567-77
pubmed: 22644327
Front Oncol. 2013 Dec 19;3:306
pubmed: 24392350
J Cell Physiol. 2018 Feb;233(2):866-879
pubmed: 28145567
Exp Mol Med. 2011 Jul 30;43(7):379-88
pubmed: 21654188
Glycoconj J. 2011 May;28(3-4):137-47
pubmed: 21519903
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9142-7
pubmed: 10430909